相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review
Patryk Kambakamba et al.
AMERICAN JOURNAL OF SURGERY (2015)
Intra-arterial Yttrium-90 Radioembolization Combined with Systemic Chemotherapy is a Promising Method for Downstaging Unresectable Huge Intrahepatic Cholangiocarcinoma to Surgical Treatment
M. Rayar et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Pathologic classification of cholangiocarcinoma: New concepts
Yasuni Nakanuma et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2015)
The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma
Matthew Howell et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2015)
Locally Advanced Intrahepatic Cholangiocarcinoma: Complete Pathologic Response to Neoadjuvant Chemotherapy Followed by Left Hepatic Trisectionectomy and Caudate Lobectomy
Thuy B. Tran et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy
T. Abe et al.
EJSO (2015)
Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study
Andrej Wagner et al.
HEPATOLOGY (2015)
Four DNA Methylation Biomarkers in Biliary Brush Samples Accurately Identify the Presence of Cholangiocarcinoma
Kim Andresen et al.
HEPATOLOGY (2015)
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Edgar Ben-Josef et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The DNA index as a prognostic tool in hilar cholangiocarcinoma
Carsten Kamphues et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
Juan W. Valle et al.
LANCET ONCOLOGY (2015)
Impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma
Katrin Hoffmann et al.
SURGERY (2015)
Intrahepatic Cholangiocarcinoma: expert consensus statement
Sharon M. Weber et al.
HPB (2015)
Hilar Cholangiocarcinoma: expert consensus statement
John C. Mansour et al.
HPB (2015)
Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Intrahepatic Cholangiocarcinoma
Lucas M. Boehm et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy
Chantal Dreyer et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
A New Clinically Based Staging System for Perihilar Cholangiocarcinoma
Roongruedee Chaiteerakij et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer
A. F. Hezel et al.
BRITISH JOURNAL OF CANCER (2014)
Chemotherapy and Targeted Therapy in Advanced Biliary Tract Carcinoma: A Pooled Analysis of Clinical Trials
Florian Eckel et al.
CHEMOTHERAPY (2014)
Aspirin May Prevent Cholangiocarcinoma: A Case-Control Study from the United Kingdom
N. E. Burr et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Hepatitis B and C Virus Infection is a Risk Factor for the Development of Cholangiocarcinoma
Kazuya Matsumoto et al.
INTERNAL MEDICINE (2014)
Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma
Shoji Kubo et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience
Sophie Duignan et al.
HPB (2014)
Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review
Jan Grendar et al.
HPB (2014)
Surgical Resection after Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer: A Retrospective Single-center Study
Atsushi Kato et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis
Omar Hyder et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Daniela Sia et al.
GASTROENTEROLOGY (2013)
Prevalence of Nonalcoholic Steatohepatitis Among Patients with Resectable Intrahepatic Cholangiocarcinoma
Srinevas K. Reddy et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Improvement in Perioperative and Long-term Outcome After Surgical Treatment of Hilar Cholangiocarcinoma Results of an Italian Multicenter Analysis of 440 Patients
Gennaro Nuzzo et al.
ARCHIVES OF SURGERY (2012)
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
Kim Andresen et al.
EPIGENETICS (2012)
Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
Jesper B. Andersen et al.
GASTROENTEROLOGY (2012)
Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
Sarwa Darwish Murad et al.
GASTROENTEROLOGY (2012)
Neither Neoadjuvant nor Adjuvant Therapy Increases Survival After Biliary Tract Cancer Resection with Wide Negative Margins
Evan S. Glazer et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy
Suzanne C. Schiffman et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
The Blumgart Preoperative Staging System for Hilar Cholangiocarcinoma: Analysis of Resectability and Outcomes in 380 Patients
Kenichi Matsuo et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
Darrell R. Borger et al.
ONCOLOGIST (2012)
Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
Marta Bonet Beltran et al.
BMC CANCER (2011)
New Staging System and a Registry for Perihilar Cholangiocarcinoma
Michelle L. DeOliveira et al.
HEPATOLOGY (2011)
SURVIVAL OUTCOMES IN RESECTED EXTRAHEPATIC CHOLANGIOCARCINOMA: EFFECT OF ADJUVANT RADIOTHERAPY IN A SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS ANALYSIS
Tamara Z. Vern-Gross et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
RADIOTHERAPY IN THE TREATMENT OF PATIENTS WITH UNRESECTABLE EXTRAHEPATIC CHOLANGIOCARCINOMA
A. Paiman Ghafoori et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment
Mechteld C. de Jong et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prevalence, gender, ethnic variations, and prognosis of NASH
Etsuko Hashimoto et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany
Thomas von Hahn et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
T. Okusaka et al.
BRITISH JOURNAL OF CANCER (2010)
Descriptive epidemiology of cholangiocarcinoma in Italy
Domenico Alvaro et al.
DIGESTIVE AND LIVER DISEASE (2010)
BRACHYTHERAPY IN THE TREATMENT OF CHOLANGIOCARCINOMA
Eric T. Shinohara et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Stereotactic fractionated radiotherapy for Klatskin tumours
Felix Momm et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Intrahepatic Cholangiocarcinoma
George A. Poultsides et al.
SURGICAL CLINICS OF NORTH AMERICA (2010)
Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors
Vincenzo Cardinale et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
Adjuvant Gemcitabine Plus S-1 Chemotherapy Improves Survival After Aggressive Surgical Resection for Advanced Biliary Carcinoma
Yoshiaki Murakami et al.
ANNALS OF SURGERY (2009)
The antecedents of biliary cancer: a primary care case-control study in the United Kingdom
M. J. Grainge et al.
BRITISH JOURNAL OF CANCER (2009)
CONCURRENT CHEMORADIOTHERAPY IN RESECTED EXTRAHEPATIC CHOLANGIOCARCINOMA
John W. Nelson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma
Yoshiaki Murakami et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: A case-control study
Tae Y. Lee et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Surgical management and prognostic factors of hilar cholangiocarcinoma: Experience with 115 cases in China
Liu Yubin et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
S. A. Khan et al.
HPB (2008)
A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer
Naohiro Yonemoto et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Risk factors for intrahepatic and extrahepatic Cholangiocarcinoma in the United States: A population-based case-control study
Tania M. Welzelt et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution
Michelle L. DeOliveira et al.
ANNALS OF SURGERY (2007)
Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials
F. Eckel et al.
BRITISH JOURNAL OF CANCER (2007)
Predictive factors for prognosis of hilar cholangiocarcinoma: Postresection radiotherapy improves survival
Q. Cheng et al.
EJSO (2007)
Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: Prognostic factors and longterm outcomes
Olivier Baton et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States
Tania M. Welzel et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Cholangiocarcinoma
T Patel
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma
N Sagawa et al.
SURGERY TODAY (2005)
Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
YH Shaib et al.
GASTROENTEROLOGY (2005)
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
YH Shaib et al.
JOURNAL OF HEPATOLOGY (2004)
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma
S Yamamoto et al.
CANCER SCIENCE (2004)
Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma:: 5-year follow-up of a prospective phase II study
M Wiedmann et al.
GASTROINTESTINAL ENDOSCOPY (2004)
Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma -: A phase II pilot study
M Wiedmann et al.
CANCER (2003)
Successful photodynamic therapy for nonresectable cholangiocarcinoma: A randomized prospective study
MEJ Ortner et al.
GASTROENTEROLOGY (2003)
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma
T Takada et al.
CANCER (2002)
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy
F Donato et al.
CANCER CAUSES & CONTROL (2001)
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998
SD Taylor-Robinson et al.
GUT (2001)
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States
T Patel
HEPATOLOGY (2001)
Prevention of implantation metastases after resection of proximal bile duct tumours with pre-operative low dose radiation therapy
MF Gerhards et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2000)
Cholangiocarcinoma in primary sclerosing cholangitis:: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development
KM Boberg et al.
JOURNAL OF HEPATOLOGY (2000)
Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma
T Todoroki et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
分享论文
